Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects
Not yet recruiting · NCT07697443 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of TQB3126 for Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Breast Cancer Subjects | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-13 | NCT07697443 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Meizhou People's Hospital | Meizhou | China | 5 |
| Sichuan Cancer Hospital | Chengdu | China | 46 |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 3 |
| The Third Xiangya Hospital of Central South University | Changsha | China | 11 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 6 |
| Zhongnan Hospital of Wuhan University | Wuhan | China | 25 |